secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vericel Corp (VCEL)
CIK:        0000887359
Form:       8-K
Filed at:   2022-08-03T23:59:59+00:00
Accession:  0001628280-22-020345
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vericel Q2 revenue $37M, net loss $9M; maintains FY guidance, NexoBrid BLA accepted with PDUFA Jan 2023
--------------------------------------------------------------------------------

- Total net revenue $37.0M (MACI $28.6M +8% YoY, Epicel $8.2M, NexoBrid $0.2M); net loss $9.0M ($0.19/sh).
- Non-GAAP adjusted EBITDA $2.8M (7% margin); operating cash flow $3.1M; cash & investments $131M, no debt.
- FY 2022 guidance reaffirmed: total revenue $178-189M, MACI $132-141M, gross margin ~69%, adj. EBITDA margin ~21%.
- NexoBrid BLA resubmission accepted by FDA; PDUFA date Jan 1, 2023.
- Entered $150M revolving credit facility with J.P. Morgan-led syndicate; issued inaugural ESG report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887359/000162828022020345/0001628280-22-020345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887359/000162828022020345/vcel-20220803.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-020345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer